Reneo Pharmaceuticals Stock Forecast - 20 Period Moving Average

RPHM Stock  USD 1.66  0.01  0.61%   
The 20 Period Moving Average forecasted value of Reneo Pharmaceuticals on the next trading day is expected to be 1.64 with a mean absolute deviation of  0.02  and the sum of the absolute errors of 0.98. Reneo Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Reneo Pharmaceuticals stock prices and determine the direction of Reneo Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Reneo Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns. Although Reneo Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Reneo Pharmaceuticals' systematic risk associated with finding meaningful patterns of Reneo Pharmaceuticals fundamentals over time.
Check out Historical Fundamental Analysis of Reneo Pharmaceuticals to cross-verify your projections.
To learn how to invest in Reneo Stock, please use our How to Invest in Reneo Pharmaceuticals guide.
  
As of the 29th of March 2024, Payables Turnover is likely to grow to 0.26. As of the 29th of March 2024, Common Stock Shares Outstanding is likely to drop to about 20.5 M. In addition to that, Net Loss is likely to drop to about (49.1 M).
Most investors in Reneo Pharmaceuticals cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the Reneo Pharmaceuticals' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets Reneo Pharmaceuticals' price structures and extracts relationships that further increase the generated results' accuracy.
A commonly used 20-period moving average forecast model for Reneo Pharmaceuticals is based on a synthetically constructed Reneo Pharmaceuticalsdaily price series in which the value for a trading day is replaced by the mean of that value and the values for 20 of preceding and succeeding time periods. This model is best suited for price series data that changes over time.

Reneo Pharmaceuticals 20 Period Moving Average Price Forecast For the 30th of March

Given 90 days horizon, the 20 Period Moving Average forecasted value of Reneo Pharmaceuticals on the next trading day is expected to be 1.64 with a mean absolute deviation of 0.02, mean absolute percentage error of 0.0009, and the sum of the absolute errors of 0.98.
Please note that although there have been many attempts to predict Reneo Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Reneo Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Reneo Pharmaceuticals Stock Forecast Pattern

Backtest Reneo PharmaceuticalsReneo Pharmaceuticals Price PredictionBuy or Sell Advice 

Reneo Pharmaceuticals Forecasted Value

In the context of forecasting Reneo Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Reneo Pharmaceuticals' downside and upside margins for the forecasting period are 0.02 and 3.39, respectively. We have considered Reneo Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
1.66
1.64
Expected Value
3.39
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the 20 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Reneo Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Reneo Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria76.1512
BiasArithmetic mean of the errors 0.0022
MADMean absolute deviation0.0234
MAPEMean absolute percentage error0.0142
SAESum of the absolute errors0.982
The eieght-period moving average method has an advantage over other forecasting models in that it does smooth out peaks and valleys in a set of daily observations. Reneo Pharmaceuticals 20-period moving average forecast can only be used reliably to predict one or two periods into the future.

Predictive Modules for Reneo Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Reneo Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Reneo Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.081.663.41
Details
Intrinsic
Valuation
LowRealHigh
1.497.679.42
Details
5 Analysts
Consensus
LowTargetHigh
23.4025.7128.54
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Reneo Pharmaceuticals. Your research has to be compared to or analyzed against Reneo Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Reneo Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Reneo Pharmaceuticals.

Other Forecasting Options for Reneo Pharmaceuticals

For every potential investor in Reneo, whether a beginner or expert, Reneo Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Reneo Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Reneo. Basic forecasting techniques help filter out the noise by identifying Reneo Pharmaceuticals' price trends.

Reneo Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Reneo Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Reneo Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Reneo Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Reneo Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Reneo Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Reneo Pharmaceuticals' current price.

Reneo Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Reneo Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Reneo Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Reneo Pharmaceuticals stock market strength indicators, traders can identify Reneo Pharmaceuticals entry and exit signals to maximize returns.

Reneo Pharmaceuticals Risk Indicators

The analysis of Reneo Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Reneo Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting reneo stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Currently Active Assets on Macroaxis

When determining whether Reneo Pharmaceuticals is a strong investment it is important to analyze Reneo Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Reneo Pharmaceuticals' future performance. For an informed investment choice regarding Reneo Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Reneo Pharmaceuticals to cross-verify your projections.
To learn how to invest in Reneo Stock, please use our How to Invest in Reneo Pharmaceuticals guide.
Note that the Reneo Pharmaceuticals information on this page should be used as a complementary analysis to other Reneo Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Complementary Tools for Reneo Stock analysis

When running Reneo Pharmaceuticals' price analysis, check to measure Reneo Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Reneo Pharmaceuticals is operating at the current time. Most of Reneo Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Reneo Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Reneo Pharmaceuticals' price. Additionally, you may evaluate how the addition of Reneo Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Share Portfolio
Track or share privately all of your investments from the convenience of any device
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Is Reneo Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Reneo Pharmaceuticals. If investors know Reneo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Reneo Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.36)
Return On Assets
(0.36)
Return On Equity
(0.59)
The market value of Reneo Pharmaceuticals is measured differently than its book value, which is the value of Reneo that is recorded on the company's balance sheet. Investors also form their own opinion of Reneo Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Reneo Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Reneo Pharmaceuticals' market value can be influenced by many factors that don't directly affect Reneo Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Reneo Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Reneo Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Reneo Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.